Preclinical pharmacokinetics of MHAA4549A, a human monoclonal antibody to influenza A virus, and the prediction of its efficacious clinical dose for the treatment of patients hospitalized with influenza A
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical pharmacokinetics of MHAA4549A, a human monoclonal antibody to influenza A virus, and the prediction of its efficacious clinical dose for the treatment of patients hospitalized with influenza A
Authors
Keywords
-
Journal
mAbs
Volume 8, Issue 5, Pages 991-997
Publisher
Informa UK Limited
Online
2016-04-02
DOI
10.1080/19420862.2016.1167294
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status
- (2014) Gonçalo Matias et al. Influenza and Other Respiratory Viruses
- Is Dosing of Therapeutic Immunoglobulins Optimal? A Review of a Three-Decade Long Debate in Europe
- (2014) Jacqueline Kerr et al. Frontiers in Immunology
- An In Vivo Human-Plasmablast Enrichment Technique Allows Rapid Identification of Therapeutic Influenza A Antibodies
- (2013) Gerald Nakamura et al. Cell Host & Microbe
- Hyperimmune IV Immunoglobulin Treatment
- (2013) Ivan F.N. Hung et al. CHEST
- Pharmacokinetics and Pharmacodynamics of ASP2151, a Helicase-Primase Inhibitor, in a Murine Model of Herpes Simplex Virus Infection
- (2012) Kiyomitsu Katsumata et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hospitalizations Associated With Influenza and Respiratory Syncytial Virus in the United States, 1993–2008
- (2012) Hong Zhou et al. CLINICAL INFECTIOUS DISEASES
- Monoclonal antibodies: what are the pharmacokinetic and pharmacodynamic considerations for drug development?
- (2012) Rong Deng et al. Expert Opinion on Drug Metabolism & Toxicology
- Surveillance of hospitalised severe cases of influenza A(H1N1)pdm09 and related fatalities in nine EU countries in 2010-2011
- (2012) René Snacken et al. Influenza and Other Respiratory Viruses
- Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data
- (2011) Rong Deng et al. mAbs
- Efficacy and Safety of Intravenous Peramivir for Treatment of Seasonal Influenza Virus Infection
- (2010) S. Kohno et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prediction of human clearance of therapeutic proteins: simple allometric scaling method revisited
- (2010) Weirong Wang et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Population Pharmacokinetics of Therapeutic Monoclonal Antibodies
- (2010) Nathanael L. Dirks et al. CLINICAL PHARMACOKINETICS
- Interspecies Scaling of Therapeutic Monoclonal Antibodies: Initial Look
- (2009) Jie Ling et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
- (2009) Jianhua Sui et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- PK/PD: new insights for antibacterial and antiviral applications
- (2008) S SCHMIDT et al. CURRENT OPINION IN PHARMACOLOGY
- The biology of influenza viruses
- (2008) Nicole M. Bouvier et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now